Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihide Yoshimi

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Blood|September 14, 2014
JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2Yuki Kagoya, Akihide Yoshimi, Takako Tsuruta-Kishino, et al.
International Journal of Clinical and Experimental Pathology|May 23, 2013
Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulationMasahiro Uni, Akihide Yoshimi, Hiroaki Maki, et al.
Blood|December 31, 2010
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cellsShunya Arai, Akihide Yoshimi, Munetake Shimabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 20, 2007
[Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]Akihide Yoshimi, Kazuki Taoka, Hideki Nakasone, et al.
Japanese Journal of Clinical Oncology|May 21, 2015
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemiaMasahiro Uni, Akihide Yoshimi, Sho Yamazaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemiaHiromitsu Iizuka, Akihide Yoshimi, Go Yamamoto, et al.
Experimental Hematology|January 16, 2021
Physical interaction between BAALC and DBN1 induces chemoresistance in leukemiaHiroaki Maki, Akihide Yoshimi, Takashi Shimada, et al.
Experimental Hematology|August 1, 2021
Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemiaAkira Honda, Junji Koya, Akihide Yoshimi, et al.
International Journal of Clinical and Experimental Pathology|October 23, 2014
Autoimmune neutropenia preceding Helicobacter pylori-negative MALT lymphoma with nodal disseminationSaori Harada, Sho Yamazaki, Fumihiko Nakamura, et al.
British Journal of Haematology|January 10, 2014
Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemiaArika Nukina, Yuki Kagoya, Naoko Watanabe-Okochi, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Blood|September 14, 2014
JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2Yuki Kagoya, Akihide Yoshimi, Takako Tsuruta-Kishino, et al.
International Journal of Clinical and Experimental Pathology|May 23, 2013
Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulationMasahiro Uni, Akihide Yoshimi, Hiroaki Maki, et al.
Blood|December 31, 2010
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cellsShunya Arai, Akihide Yoshimi, Munetake Shimabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 20, 2007
[Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]Akihide Yoshimi, Kazuki Taoka, Hideki Nakasone, et al.
Japanese Journal of Clinical Oncology|May 21, 2015
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemiaMasahiro Uni, Akihide Yoshimi, Sho Yamazaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemiaHiromitsu Iizuka, Akihide Yoshimi, Go Yamamoto, et al.
Experimental Hematology|January 16, 2021
Physical interaction between BAALC and DBN1 induces chemoresistance in leukemiaHiroaki Maki, Akihide Yoshimi, Takashi Shimada, et al.
Experimental Hematology|August 1, 2021
Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemiaAkira Honda, Junji Koya, Akihide Yoshimi, et al.
International Journal of Clinical and Experimental Pathology|October 23, 2014
Autoimmune neutropenia preceding Helicobacter pylori-negative MALT lymphoma with nodal disseminationSaori Harada, Sho Yamazaki, Fumihiko Nakamura, et al.
British Journal of Haematology|January 10, 2014
Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemiaArika Nukina, Yuki Kagoya, Naoko Watanabe-Okochi, et al.
Pageof 10